CRON vs LEN · P/E 14, rev $117.6M vs rev $34.19B
Cronos Group Inc (CRON) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
Cronos Group Inc (CRON) is a drug manufacturers - specialty & generic company listed on US.
LEN (LEN) common stock.
Latest reported CRON revenue for 2024-12-31 was $117.6M. Net income was $40.0M. Revenue was up 34.8% from 2023-12-31 to 2024-12-31. CRON currently screens at market cap $738.3M and trailing P/E 13.6.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
CRON currently screens at market cap $738.3M and trailing P/E 13.6. LEN currently screens at market cap $0.
Not investment advice. Open the CRON and LEN stock pages for the full models.
Not investment advice.